Compounds fend off Alzheimer's disease amyloid pathology
Wednesday, September 8, 2010 - 12:07
in Health & Medicine
A team of scientists, led by University of California, San Diego School of Medicine researchers, has synthesized hundreds of new compounds with the potential of reducing the production of the A-beta 42 peptide, a primary component of Alzheimer's disease (AD).